🔴 Noveris Health Sciences is trading 5.2% down today following regulatory setbacks and a multi-year trading halt

Noveris Health Sciences is trading at CA$1.29, down 5.2% today, as the stock faces continued pressure from a significant regulatory overhang and broader weakness in the biotechnology sector.

• The British Columbia Securities Commission (BCSC) has halted trading in the company's shares until April 16, 2026, due to disclosure issues regarding its Listed Issuer Financing Exemption (LIFE) offering.
• Management clarified that the LIFE offering failed to qualify, resulting in the cancellation and reissuance of securities with restrictive hold periods.
• The stock has seen several consecutive declines this week as sentiment remains weighed down by these administrative challenges and industry-wide volatility.